Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price targe...
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $16.5 to $23.
Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $...
Leerink Partners analyst Whit Mayo maintains Pediatrix Medical Group (NYSE:MD) with a Market Perform and raises the price ta...
Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced that its Board of Directors ...
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $16 to $16.5.
